Imiquimod: a potential role in dermatology?
- 1 July 2002
- journal article
- review article
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 147 (1), 1-6
- https://doi.org/10.1046/j.1365-2133.2002.04945.x
Abstract
No abstract availableThis publication has 57 references indexed in Scilit:
- Small anti-viral compounds activate immune cells via the TLR7 MyD88–dependent signaling pathwayNature Immunology, 2002
- Treatment of recalcitrant plantar warts with imiquimodJournal of Dermatological Treatment, 2002
- Treatment of Anogenital Warts in Children with Topical 0.05% Podofilox Gel and 5% Imiquimod CreamPediatric Dermatology, 2001
- Letters to the EditorPublished by Medical Journals Sweden AB ,2000
- Imiquimod, a Topical Immune Response Modifier, Induces Migration of Langerhans Cells11The authors have declared a conflict of interest.Journal of Investigative Dermatology, 2000
- Therapeutic response of basal cell carcinoma to the immune response modifier imiquimod 5% creamJournal of the American Academy of Dermatology, 1999
- Review Article Imiquimod applied topically: a novel immune response modifier and new class of drugInternational Journal of Immunopharmacology, 1999
- Effect of a Novel Topical Immunomodulator, S-28463, on Keratinocyte Cytokine Gene Expression and ProductionJournal of Interferon & Cytokine Research, 1996
- Cellular Requirements for Cytokine Production in Response to the Immunomodulators Imiquimod and S-27609Journal of Interferon & Cytokine Research, 1995